Press "Enter" to skip to content

Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) Market Share, Size 2019-2024 | Industry Analysis, Overview of Market Dynamics, Top Key Players, and Regional Forecast to 2024

Europe

The “Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) Market” report 2019 covers all the significant developments which are recently being adopted across the global market. The prime objective of Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) market report is to provides an in-depth analysis of all market dynamics including drivers and restraints, and trends and opportunities. The Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) market report covers both the demand and supply aspect of the market. The report also highlighted the future trends in the Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) market that will impact the demand during the forecast period.

Scope of the Report:

  • The report includes a complete study of SGLT2 inhibitors, which include invokana, jardiance, farxiga, and suglat. The study is further divided into country-wise analysis, which cover all the drugs in the SGLT-2 class.

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14245085

    Market Overview:

  • – Jardiance has the highest growth among all the drugs in the SGLT2 class, in terms of revenue, with an expected CAGR of about 22.51%, during the forecast period (2019-2024). Jardiance was reported to have less cardiovascular risk among other oral drugs.
  • – The sodium-dependent glucose cotransporter 2 (SGLT2) market is expected to witness tremendous growth during the forecast period (2019-2024), with a CAGR of 17%, mainly due to the drugs jardiance and farxiga/forxiga.
  • – Jardiance is a once-daily oral medication that is used to control blood glucose levels in people with type 2 diabetes.

    Some of the Top Key Players of Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) Market Report Are:

  • Eli Lilly
  • Janssen Pharmaceuticals
  • Boehringer Ingelheim
  • AstraZeneca
  • Bristol Myers Squibb

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    For More Information or Query or Customization Before Buying, Visit athttps://www.industryresearch.co/enquiry/pre-order-enquiry/14245085

    Key Market Trends:

    Increasing Side Effects of Invokana

    – Drugs for diabetes are rather expensive for a large segment (middle-class or lower middle-class population) of diabetic patients.
    – While there are only a few moderately priced-generics, like the metformin drugs, other medicines are often more costly and have fewer side effects.
    – One such drug that is losing ground is Johnson & Johnson’s Invokana, due to its increasing side effects.
    – In May, US regulators mandated that the pharmaceutical giant needs to add warnings to Invokana’s label about an increased risk of leg and foot amputations, and in the following month, the company’s cardiovascular outcomes trial, Canvas, confirmed that the medication increased the rate of amputations by about twofold.

    Increasing Diabetic Population

    – As there is an exponential growth of diabetic population YoY, especially type 2 diabetic patients, new innovative drugs are coming up in the market to increase the ease of access to the patients.
    – With the increase in diabetic population, the need and demand for diabetes drugs are expected to increase. The other factors, such as better adoption than other therapies and government initiatives, are driving the diabetes drugs market.

    The Report Covers:

    • Comprehensive research methodology of Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) market
    • In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
    • Analysis of regional regulations and other government policies impacting the global sleep aid market
    • Insights about market determinants which are stimulating the global Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) market
    • Detailed and extensive market segments with regional distribution of forecasted revenues
    • Extensive profiles and recent developments of market players Companies Mentioned

    Purchase this Report (Price 3850 USD for single user license) – https://www.industryresearch.co/purchase/14245085

    Detailed TOC of Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Drivers
    4.3 Restraints
    4.4 Porter’s Five Forces Analysis
    4.4.1 Bargaining Power of Suppliers
    4.4.2 Bargaining Power of Consumers
    4.4.3 Threat of New Entrants
    4.4.4 Threat of Substitute Products and Services
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Drug
    5.1.1 Sodium-dependent Glucose Cotransport 2 (SGLT-2) Inhibitor (Value and Volume, 2012-2024)
    5.1.1.1 Invokana (Canagliflozin)
    5.1.1.2 Jardiance (Empagliflozin)
    5.1.1.3 Farxiga/Forxiga (Dapagliflozin)
    5.1.1.4 Suglat (Ipragliflozin)
    5.2 By Geography
    5.2.1 Europe
    5.2.1.1 France (Value and Volume, 2012-2024)
    5.2.1.1.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.1.2 Germany (Value and Volume, 2012-2024)
    5.2.1.2.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.1.3 Italy (Value and Volume, 2012-2024)
    5.2.1.3.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.1.4 Spain (Value and Volume, 2012-2024)
    5.2.1.4.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.1.5 United Kingdom (Value and Volume, 2012-2024)
    5.2.1.5.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.1.6 Russia (Value and Volume, 2012-2024)
    5.2.1.6.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.1.7 Rest of Europe (Value and Volume, 2012-2024)
    5.2.1.7.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)

    6 MARKET INDICATORS
    6.1 Type-1 Diabetes Population (2012-2024)
    6.2 Type-2 Diabetes Population (2012-2024)

    7 COMPETITIVE LANDSCAPE
    7.1 COMPANY PROFILES
    7.1.1 Eli Lilly
    7.1.2 Janssen Pharmaceuticals
    7.1.3 Boehringer Ingelheim
    7.1.4 AstraZeneca
    7.1.5 Bristol Myers Squibb
    7.2 MARKET SHARE ANALYSIS
    7.2.1 Eli Lilly
    7.2.2 Janssen Pharmaceuticals
    7.2.3 Boehringer Ingelheim
    7.2.4 AstraZeneca

    8 MARKET OPPORTUNITES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Implantable Neurostimulators Market 2019 Industry Recent Developments, Size, Trends, Global Growth, Recent Developments and Latest Technology, Forecast Research Report 2024

    Global Drawing Pencil Market Size 2019 | Emerging Trends, Industry Share, Future Demands, Market Potential, Traders, Regional Overview and SWOT Analysis till 2024

    Global Smart Hoverboard Electric Scooter Market Size & share 2019: Subdivision by, Challenges and Key Findings Forecast 2025

    Big Enter Key Industry Forecast to 2025 with Global Key Companies Profile, Market Size, Supply, Demand, Cost Structure and Forecast 2019 to 2025

  • Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *